Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(22%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
11%
Ph phase_2
3
33%
Ph not_applicable
5
56%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
3(33.3%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(6)
Other(1)

Detailed Status

Completed6
Recruiting1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (11.1%)
Phase 23 (33.3%)
N/A5 (55.6%)

Trials by Status

recruiting111%
unknown111%
completed667%
active_not_recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
9